Annual Cash & Cash Equivalents
$117.10 M
+$4.61 M+4.10%
31 December 2023
Summary:
HOOKIPA Pharma annual cash & cash equivalents is currently $117.10 million, with the most recent change of +$4.61 million (+4.10%) on 31 December 2023. During the last 3 years, it has fallen by -$25.65 million (-17.97%). HOOK annual cash & cash equivalents is now -17.97% below its all-time high of $142.74 million, reached on 31 December 2020.HOOK Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$59.75 M
-$17.40 M-22.55%
30 September 2024
Summary:
HOOKIPA Pharma quarterly cash and cash equivalents is currently $59.75 million, with the most recent change of -$17.40 million (-22.55%) on 30 September 2024. Over the past year, it has dropped by -$47.93 million (-44.51%). HOOK quarterly cash and cash equivalents is now -58.14% below its all-time high of $142.74 million, reached on 31 December 2020.HOOK Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HOOK Cash And Cash Equivalents Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +4.1% | -44.5% |
3 y3 years | -18.0% | -27.4% |
5 y5 years | +141.0% | -51.7% |
HOOK Cash And Cash Equivalents High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -18.0% | +77.6% | -57.6% | at low |
5 y | 5 years | -18.0% | +141.0% | -58.1% | at low |
alltime | all time | -18.0% | +141.0% | -58.1% | +23.0% |
HOOKIPA Pharma Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $59.75 M(-22.6%) |
June 2024 | - | $77.15 M(-16.8%) |
Mar 2024 | - | $92.75 M(-20.8%) |
Dec 2023 | $117.10 M(+4.1%) | $117.10 M(+8.7%) |
Sept 2023 | - | $107.68 M(-20.6%) |
June 2023 | - | $135.59 M(+23.7%) |
Mar 2023 | - | $109.60 M(-2.6%) |
Dec 2022 | $112.49 M(+70.6%) | $112.49 M(+12.7%) |
Sept 2022 | - | $99.78 M(-15.4%) |
June 2022 | - | $117.92 M(-16.3%) |
Mar 2022 | - | $140.82 M(+113.6%) |
Dec 2021 | $65.92 M | $65.92 M(-19.9%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2021 | - | $82.27 M(-19.8%) |
June 2021 | - | $102.52 M(-19.7%) |
Mar 2021 | - | $127.72 M(-10.5%) |
Dec 2020 | $142.74 M(+26.2%) | $142.74 M(+74.4%) |
Sept 2020 | - | $81.83 M(-11.9%) |
June 2020 | - | $92.86 M(-11.1%) |
Mar 2020 | - | $104.45 M(-7.7%) |
Dec 2019 | $113.15 M(+132.9%) | $113.15 M(-8.5%) |
Sept 2019 | - | $123.69 M(-8.3%) |
June 2019 | - | $134.89 M(+91.3%) |
Mar 2019 | - | $70.51 M(+45.1%) |
Dec 2018 | $48.58 M(-20.8%) | $48.58 M |
Dec 2017 | $61.36 M | - |
FAQ
- What is HOOKIPA Pharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for HOOKIPA Pharma?
- What is HOOKIPA Pharma annual cash & cash equivalents year-on-year change?
- What is HOOKIPA Pharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for HOOKIPA Pharma?
- What is HOOKIPA Pharma quarterly cash and cash equivalents year-on-year change?
What is HOOKIPA Pharma annual cash & cash equivalents?
The current annual cash & cash equivalents of HOOK is $117.10 M
What is the all time high annual cash & cash equivalents for HOOKIPA Pharma?
HOOKIPA Pharma all-time high annual cash & cash equivalents is $142.74 M
What is HOOKIPA Pharma annual cash & cash equivalents year-on-year change?
Over the past year, HOOK annual cash & cash equivalents has changed by +$4.61 M (+4.10%)
What is HOOKIPA Pharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of HOOK is $59.75 M
What is the all time high quarterly cash and cash equivalents for HOOKIPA Pharma?
HOOKIPA Pharma all-time high quarterly cash and cash equivalents is $142.74 M
What is HOOKIPA Pharma quarterly cash and cash equivalents year-on-year change?
Over the past year, HOOK quarterly cash and cash equivalents has changed by -$47.93 M (-44.51%)